ClinicalTrialsFinder

NK/T-cell Lymphoma Clinical Trials in Beijing, Haidian

1 recruitingBeijing, Haidian, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

Advanced LymphomaNewly DiagnosedNK/T-cell Lymphoma
Chinese PLA General Hospital10 enrolled1 locationNCT05833893